S&P cuts Ethypharm

S&P said it lowered the issuer credit rating on Ethypharm's parent, Financiere Verdi I SAS, to B- from B and also lowered the issue rating on the first-lien debt instrument to B- from B.

The outlook is stable.

“The stable outlook reflects our view that the company's operating performance will remain stable in 2021-2022, supporting debt leverage at around 7.5x and adequate liquidity in the next 12-18 months,” S&P said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.